Spotlight: Rare Diseases and Innovative Therapies

In this Spotlight on Rare Diseases and Innovative Therapies, we’re delighted to feature this insightful discussion around exploring agile strategies to accelerate collaboration and patient focus for rare diseases in a post-COVID Europe.

This virtual spotlight event includes a mix of six expert videos, as well as a panel discussion on accelerated regulatory approval in 2022 and beyond, and a Fireside chat with Jean-Christophe Novelli, who discusses the human impact of rare diseases from his first-hand experiences. We hope this Spotlight can provide insights on the utilization of real-world evidence (RWE) in rare diseases and innovative therapies.

WATCH OUR FIRESIDE CHAT WITH JEAN-CHRISTOPHE NOVELLI: THE HUMAN IMPACT OF RARE DISEASES

WATCH OUR PANEL DISCUSSION: ACCELERATED REGULATORY APPROVAL IN 2022 AND BEYOND – MANAGING UNCERTAINTY WITH THE IMPACTS OF BREXIT AND COVID-19